The concept of “precision medicine,” an emerging approach using the genetic changes in a patient’s tumor to determine their disease treatment and prevention, can be seen as a new epoch in cancer management. Extracellular vesicles and exosomes are of high interest in the scientific community due to their role in intercellular communications. Especially the role… Read article →
Laura Alina Mohr, M.Sc.
Laura Alina Mohr joined QIAGEN in 2015. She received her Master’s Degree in Chemical Biology at the Technical University Dortmund in Germany. During this time, she was involved in Systemic Cell Biology research at the prestigious Max Planck Institute. Before joining QIAGEN, Laura Alina worked at the Scripps Research Institute, San Diego, where she first focused on DNA damage/repair pathways and telomere biology. Later, she joined the Muscle Development, Aging and Regeneration program at the Sanford Burnham Prebys Medical Discovery Institute. At QIAGEN she is interested in gene expression profiling focusing on various biological pathways, e.g. cancer research and neurodegeneration.